Dendritic cell–intrinsic LKB1-AMPK/SIK signaling controls metabolic homeostasis by limiting the hepatic Th17 response during obesity
暂无分享,去创建一个
B. Everts | M. Yazdanbakhsh | E. Brombacher | A. Zawistowska-Deniziak | B. Guigas | T. Patente | Hendrik J. P. van der Zande | G. Heieis | A. Ozir-Fazalalikhan | L. Pelgrom | Frank Otto | J. Lambooij | F. Otto
[1] X. Ruan,et al. CD36 promotes de novo lipogenesis in hepatocytes through INSIG2-dependent SREBP1 processing , 2021, Molecular metabolism.
[2] J Zhang,et al. OTUB1 alleviates NASH through inhibition of the TRAF6‐ASK1 signaling pathways , 2021, Hepatology.
[3] M. Giera,et al. Effects of a novel polyphenol-rich plant extract on body composition, inflammation, insulin sensitivity, and glucose homeostasis in obese mice , 2021, International Journal of Obesity.
[4] I. Amit,et al. XCR1+ type 1 conventional dendritic cells drive liver pathology in non-alcoholic steatohepatitis , 2021, Nature Medicine.
[5] Amy S. Shah,et al. PKM2-dependent metabolic skewing of hepatic Th17 cells regulates pathogenesis of non-alcoholic fatty liver disease. , 2021, Cell metabolism.
[6] Xiaozhen Dai,et al. Sodium Butyrate Supplementation Inhibits Hepatic Steatosis by Stimulating Liver Kinase B1 and Insulin-Induced Gene , 2021, Cellular and molecular gastroenterology and hepatology.
[7] A. Albillos,et al. The Role of the Gut-Liver Axis in Metabolic Dysfunction-Associated Fatty Liver Disease , 2021, Frontiers in Immunology.
[8] N. Djouder,et al. Inhibition of the IL-17A axis in adipocytes suppresses diet-induced obesity and metabolic disorders in mice , 2021, Nature Metabolism.
[9] Jun Weng,et al. HFD-induced TRAF6 upregulation promotes liver cholesterol accumulation and fatty liver development via EZH2-mediated miR-429/PPARα axis , 2021, Molecular therapy. Nucleic acids.
[10] Alexander S. Banks,et al. KLF10 Deficiency in CD4+ T Cells Triggers Obesity, Insulin Resistance, and Fatty Liver , 2020, Cell reports.
[11] S. Ramakrishnan,et al. Tregs facilitate obesity and insulin resistance via a Blimp-1/IL-10 axis , 2020, JCI insight.
[12] B. Everts,et al. Shaping of Dendritic Cell Function by the Metabolic Micro-Environment , 2020, Frontiers in Endocrinology.
[13] Y. Saeys,et al. Osteopontin Expression Identifies a Subset of Recruited Macrophages Distinct from Kupffer Cells in the Fatty Liver , 2020, Immunity.
[14] Jian-ping Guo,et al. The potent roles of salt-inducible kinases (SIKs) in metabolic homeostasis and tumorigenesis , 2020, Signal Transduction and Targeted Therapy.
[15] Maxim N. Artyomov,et al. Open Source ImmGen: network perspective on metabolic diversity among mononuclear phagocytes , 2020, bioRxiv.
[16] P. Loke,et al. The helminth glycoprotein omega‐1 improves metabolic homeostasis in obese mice through type 2 immunity‐independent inhibition of food intake , 2020, bioRxiv.
[17] M. Levings,et al. T reg–specific insulin receptor deletion prevents diet-induced and age-associated metabolic syndrome , 2020, The Journal of experimental medicine.
[18] T. Matozaki,et al. SIRPα on CD11c+ cells induces Th17 cell differentiation and subsequent inflammation in the CNS in experimental autoimmune encephalomyelitis , 2020, European journal of immunology.
[19] A. Zawistowska-Deniziak,et al. Immune Regulation of Metabolic Homeostasis by Helminths and Their Molecules. , 2019, Trends in parasitology.
[20] B. Everts,et al. Dendritic cells are what they eat: how their metabolism shapes T helper cell polarization. , 2019, Current opinion in immunology.
[21] B. Everts,et al. LKB1 expressed in dendritic cells governs the development and expansion of thymus-derived regulatory T cells , 2019, Cell Research.
[22] H. Chi,et al. LKB1 orchestrates dendritic cell metabolic quiescence and anti-tumor immunity , 2019, Cell Research.
[23] D. Brenner,et al. The TNF Family of Ligands and Receptors: Communication Modules in the Immune System and Beyond. , 2019, Physiological reviews.
[24] W. Guo,et al. Control of Treg cell homeostasis and immune equilibrium by Lkb1 in dendritic cells , 2018, Nature Communications.
[25] R. Xavier,et al. Salt-Inducible Kinases: Physiology, Regulation by cAMP, and Therapeutic Potential , 2018, Trends in Endocrinology & Metabolism.
[26] J. Lovato,et al. Obesity-Linked Gut Microbiome Dysbiosis Associated with Derangements in Gut Permeability and Intestinal Cellular Homeostasis Independent of Diet , 2018, Journal of diabetes research.
[27] R. Evans,et al. Metabolic control of regulatory T cell (Treg) survival and function by Lkb1 , 2017, Proceedings of the National Academy of Sciences.
[28] B. Viollet,et al. Chronic Intermittent Hypoxia Impairs Insulin Sensitivity but Improves Whole-Body Glucose Tolerance by Activating Skeletal Muscle AMPK , 2017, Diabetes.
[29] Huijue Jia,et al. Gut microbiome and serum metabolome alterations in obesity and after weight-loss intervention , 2017, Nature Medicine.
[30] Liguo Zhang,et al. Cilostazol Suppresses IL-23 Production in Human Dendritic Cells via an AMPK-Dependent Pathway , 2016, Cellular Physiology and Biochemistry.
[31] Eran Segal,et al. Persistent microbiome alterations modulate the rate of post-dieting weight regain , 2016, Nature.
[32] K. Murphy,et al. Functions of Murine Dendritic Cells. , 2016, Immunity.
[33] Lindsey A. Muir,et al. Adipose Tissue Dendritic Cells Are Independent Contributors to Obesity-Induced Inflammation and Insulin Resistance , 2016, The Journal of Immunology.
[34] A. Waisman,et al. Metabolic Inflammation-Associated IL-17A Causes Non-alcoholic Steatohepatitis and Hepatocellular Carcinoma. , 2016, Cancer cell.
[35] B. Viollet,et al. Myeloid-Restricted AMPKα1 Promotes Host Immunity and Protects against IL-12/23p40–Dependent Lung Injury during Hookworm Infection , 2016, The Journal of Immunology.
[36] C. Gilliéron,et al. SIK inhibition in human myeloid cells modulates TLR and IL‐1R signaling and induces an anti‐inflammatory phenotype , 2016, Journal of leukocyte biology.
[37] F. Novelli,et al. The balance between IL-17 and IL-22 produced by liver-infiltrating T-helper cells critically controls NASH development in mice. , 2016, Clinical science.
[38] D. Erion,et al. Hepatocyte-Specific Disruption of CD36 Attenuates Fatty Liver and Improves Insulin Sensitivity in HFD-Fed Mice. , 2016, Endocrinology.
[39] H. Hermanns,et al. Progression from Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis Is Marked by a Higher Frequency of Th17 Cells in the Liver and an Increased Th17/Resting Regulatory T Cell Ratio in Peripheral Blood and in the Liver , 2016, The Journal of Immunology.
[40] M. Levings,et al. IL-33 Reverses an Obesity-Induced Deficit in Visceral Adipose Tissue ST2+ T Regulatory Cells and Ameliorates Adipose Tissue Inflammation and Insulin Resistance , 2015, The Journal of Immunology.
[41] M. Yazdanbakhsh,et al. Chronic helminth infection and helminth‐derived egg antigens promote adipose tissue M2 macrophages and improve insulin sensitivity in obese mice , 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[42] Xuetao Cao,et al. Histone Lysine Methyltransferase Ezh1 Promotes TLR-Triggered Inflammatory Cytokine Production by Suppressing Tollip , 2015, The Journal of Immunology.
[43] B. Everts,et al. Dendritic cell metabolism , 2014, Nature Reviews Immunology.
[44] Miao Zhang,et al. Liver Kinase B1 Suppresses Lipopolysaccharide-induced Nuclear Factor κB (NF-κB) Activation in Macrophages* , 2014, The Journal of Biological Chemistry.
[45] Charlotte L. Scott,et al. Signal regulatory protein alpha (SIRPα) regulates the homeostasis of CD103+CD11b+ DCs in the intestinal lamina propria , 2014, European journal of immunology.
[46] Daniel J. O'Connell,et al. Small-molecule screening identifies inhibition of salt-inducible kinases as a therapeutic strategy to enhance immunoregulatory functions of dendritic cells , 2014, Proceedings of the National Academy of Sciences.
[47] A. Gormand,et al. LKB1 signalling attenuates early events of adipogenesis and responds to adipogenic cues. , 2014, Journal of molecular endocrinology.
[48] Rohit Kohli,et al. IL-17 Signaling Accelerates the Progression of Nonalcoholic Fatty Liver Disease in Mice , 2014, Hepatology.
[49] D. Alessi,et al. Investigation of LKB1 Ser431 phosphorylation and Cys433 farnesylation using mouse knockin analysis reveals an unexpected role of prenylation in regulating AMPK activity , 2013, The Biochemical journal.
[50] E. Jung,et al. Salt-inducible kinases 1 and 3 negatively regulate Toll-like receptor 4-mediated signal. , 2013, Molecular endocrinology.
[51] B. Ryffel,et al. IL-17A Plays a Critical Role in the Pathogenesis of Liver Fibrosis through Hepatic Stellate Cell Activation , 2013, The Journal of Immunology.
[52] M. Colonna,et al. Accepted Manuscript Association Between Specific Adipose Tissue CD 4 + T-Cell Populations and Insulin Resistance in Obese People , 2013 .
[53] R. Locksley,et al. Innate lymphoid type 2 cells sustain visceral adipose tissue eosinophils and alternatively activated macrophages , 2013, The Journal of experimental medicine.
[54] D. Ganea,et al. Prostaglandin E2-induced IL-23p19 Subunit Is Regulated by cAMP-responsive Element-binding Protein and C/AATT Enhancer-binding Protein β in Bone Marrow-derived Dendritic Cells* , 2012, The Journal of Biological Chemistry.
[55] D. Stolz,et al. Dendritic Cells Promote Macrophage Infiltration and Comprise a Substantial Proportion of Obesity-Associated Increases in CD11c+ Cells in Adipose Tissue and Liver , 2012, Diabetes.
[56] J. Gugenheim,et al. Identification of Adipose Tissue Dendritic Cells Correlated With Obesity-Associated Insulin-Resistance and Inducing Th17 Responses in Mice and Patients , 2012, Diabetes.
[57] A. Regev,et al. Induction and molecular signature of pathogenic TH17 cells , 2012, Nature Immunology.
[58] D. Hommes,et al. Autophagy attenuates the adaptive immune response by destabilizing the immunologic synapse. , 2012, Gastroenterology.
[59] Q. Wang,et al. Interleukin‐17 exacerbates hepatic steatosis and inflammation in non‐alcoholic fatty liver disease , 2011, Clinical and experimental immunology.
[60] R. Locksley,et al. Eosinophils Sustain Adipose Alternatively Activated Macrophages Associated with Glucose Homeostasis , 2011, Science.
[61] S. Tangye,et al. Inflammatory Mechanisms in Obesity , 2013 .
[62] M. Montminy,et al. CREB and the CRTC co-activators: sensors for hormonal and metabolic signals , 2011, Nature Reviews Molecular Cell Biology.
[63] J. González‐Gallego,et al. Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C , 2011, Gut.
[64] L. Joosten,et al. The inflammasome-mediated caspase-1 activation controls adipocyte differentiation and insulin sensitivity. , 2010, Cell metabolism.
[65] Robert Booth,et al. Faculty Opinions recommendation of Generation of pathogenic T(H)17 cells in the absence of TGF-β signalling. , 2010 .
[66] T. Holowka,et al. Toll-like receptor-induced changes in glycolytic metabolism regulate dendritic cell activation. , 2010, Blood.
[67] Christophe Benoist,et al. Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters , 2009, Nature Medicine.
[68] R. Shaw,et al. The LKB1–AMPK pathway: metabolism and growth control in tumour suppression , 2009, Nature Reviews Cancer.
[69] R. Silverstein,et al. CD36, a Scavenger Receptor Involved in Immunity, Metabolism, Angiogenesis, and Behavior , 2009, Science Signaling.
[70] E. Barillot,et al. A critical function for transforming growth factor-β, interleukin 23 and proinflammatory cytokines in driving and modulating human TH-17 responses , 2008, Nature Immunology.
[71] D. Greco,et al. Gene expression in human NAFLD. , 2008, American journal of physiology. Gastrointestinal and liver physiology.
[72] Peter F. Johnson,et al. Transcriptional Regulation of Fatty Acid Translocase/CD36 Expression by CCAAT/Enhancer-binding Protein α* , 2008, Journal of Biological Chemistry.
[73] M. Zou,et al. Phosphorylation of LKB1 at Serine 428 by Protein Kinase C-&zgr; Is Required for Metformin-Enhanced Activation of the AMP-Activated Protein Kinase in Endothelial Cells , 2008, Circulation.
[74] J. Dyck,et al. Increased Hepatic CD36 Expression Contributes to Dyslipidemia Associated With Diet-Induced Obesity , 2007, Diabetes.
[75] R. Ravi,et al. A high‐fat diet and regulatory T cells influence susceptibility to endotoxin‐induced liver injury , 2007, Hepatology.
[76] B. Reizis,et al. Notch–RBP-J signaling controls the homeostasis of CD8− dendritic cells in the spleen , 2007, The Journal of experimental medicine.
[77] D. Alessi,et al. Identification of the sucrose non‐fermenting related kinase SNRK, as a novel LKB1 substrate , 2005, FEBS letters.
[78] Jérôme Boudeau,et al. LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR‐1 , 2004, The EMBO journal.
[79] G. Sapkota,et al. Phosphorylation of the Protein Kinase Mutated in Peutz-Jeghers Cancer Syndrome, LKB1/STK11, at Ser431 by p90RSK and cAMP-dependent Protein Kinase, but Not Its Farnesylation at Cys433, Is Essential for LKB1 to Suppress Cell Growth* , 2001, The Journal of Biological Chemistry.
[80] S. Stinnett,et al. Cyclic AMP signaling pathways are important in IL-1 beta transcriptional regulation. , 1995, Journal of immunology.
[81] T. Libermann,et al. Multiple regulatory elements in the interleukin-6 gene mediate induction by prostaglandins, cyclic AMP, and lipopolysaccharide , 1994, Molecular and cellular biology.
[82] R. Shaw,et al. The AMPK-related kinases SIK1 and SIK3 mediate key tumor suppressive effects of LKB1 in NSCLC. , 2019, Cancer discovery.
[83] J. Dyck,et al. Increased Hepatic CD 36 Expression Contributes to Dyslipidemia Associated with Diet-Induced Obesity , 2007 .
[84] B. Spiegelman,et al. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. , 1993, Science.